Complete Up To Date Information about Flavomycin / Stenorol .
NADA Number: 140-918 | |
| Proprietary Name |
Flavomycin® / Stenorol® |
|---|---|
| Sponsor |
Huvepharma AD |
| Sponsor Address |
33 James Boucher Blvd. Sophia 1407, Bulgaria |
| Ingredients |
Halofuginone Hydrobromide Bambermycins |
| Species |
Turkey, growing |
| Routes of Administration |
Per Os |
| Dose Form |
Medicated feed |
| Drug Form |
Type A Medicated Article |
| Dispensing Status |
OTC |
| Exclusivity |
Granted for the prevention of coccidiosis and increased weight gain in turkeys. |
| Withdrawal Time |
Growing Turkey: 7 days before slaughter. |
|
Dosage Amount, Indications & Limitations |
558.265 Halofuginone hydrobromide. Specifications: Halofuginone hydrobromide Type A medicated article (2.72 grams per pound) and bambermycins Type A medicated article (4 and 10 grams per pound) to make Type C medicated turkey feeds containing 1.36 to 2.72 grams per ton of halofuginone hydrobromide and 2 grams of bambermycins per ton. The use of halofuginone hydrobromide and bambermycins Type A articles to make Type C medicated turkey feeds requires an approved form FDA 1900. Conditions of use: Turkeys (growing) Amount: 1.36 to 2.72 grams of halofuginone hydrobromide per ton of feed and 2 grams of bambermycins per ton of feed. Indications: For the prevention of coccidiosis caused by E. adenoeides, E. meleagrimitis, and E. gallopavonis, and for increased rate of weight gain in growing turkeys. Limitations: Feed continuously as sole ration. Withdraw 7 days before slaughter. Do not feed to laying chickens or waterfowl. Halofuginone hydrobromide is toxic to fish and other aquatic life. Keep out of lakes, ponds and streams. Halofuginone hydrobromide is an eye and skin irritant. Avoid contact with skin, eyes, and clothing. |
| Tolerances |
The marker residue selected to monitor for total residues of halofuginone hydrobromide in broilers and turkeys is parent halofuginone hydrobromide and the target tissue selected is liver. A tolerance is established in broilers of 0.16 part per million and in turkeys of 0.13 part per million for parent halofuginone hydrobromide in liver. These marker residue concentrations in liver correspond to total residue concentrations of 0.3 part per million in liver. |